News

Filter

Current filters:

None

37 to 46 of 97856 results

Shire acquires Meritage Pharma, strengthening rare diseases pipeline

Shire acquires Meritage Pharma, strengthening rare diseases pipeline

24-02-2015

In a second acquisition this year, Ireland-headquartered Shire revealed today that it has taken control…

BiotechnologyGastro-intestinalsMergers & AcquisitionsMeritage PharmaRare diseasesShire

Pfizer reports positive top-line data for Trumenba Phase II study in adolescents

Pfizer reports positive top-line data for Trumenba Phase II study in adolescents

24-02-2015

US pharma giant Pfizer has announced positive top-line results of a Phase II study of Trumenba (meningococcal…

Antibiotics and Infectious diseasesPfizerPharmaceuticalResearchTrumenbaUSA

AusBiotech comments on draft IP Toolkit for research collaboration

24-02-2015

Trade group AusBiotech has made a submission on intellectual property to IP Australia on the draft IP…

AustraliaBiotechnologyPatents & Trade marks

Considerable commercial interest in Alzheimer's pipeline despite high rate of attrition, report says

Considerable commercial interest in Alzheimer's pipeline despite high rate of attrition, report says

24-02-2015

Despite a high rate of attrition, there is a considerable level of commercial interest in the Alzheimer’s…

AlzheimerGBI ResearchNeurologicalPharmaceuticalResearch

30% increase in R&D projects for neglected diseases in 2014; report

24-02-2015

Trade group the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA) has released…

GlobalPharmaceuticalResearchTropical diseases

Federal Trade Commission puts conditions on Novartis acquisition of GSK oncology portfolio

Federal Trade Commission puts conditions on Novartis acquisition of GSK oncology portfolio

24-02-2015

The US Federal Trade Commission has put conditions on the proposed acquisition by Novartis of GlaxoSmithKline’s…

Array BioPharmaGSKLegalMergers & AcquisitionsNovartisOncologyPharmaceuticalRegulationResearchUSA

Merck enters into collaboration with NGM to develop biologics

Merck enters into collaboration with NGM to develop biologics

24-02-2015

Pharma giant Merck & Co has entered into a collaboration with privately-held biotech company NGM Biopharmaceuticals…

BiotechnologyMerck & CoNGM BiopharmaceuticalsResearchUSA

Ipsen pays 6 million euros for option to acquire Canbex

24-02-2015

French drugmaker Ipsen today announced that UK-based biotech firm Canbex Therapeutics has granted an…

BiotechnologyCanbex TherapeuticsIpsenMergers & AcquisitionsNeurologicalVSN16R

Marathon Pharma sells non-strategic products to Valeant

24-02-2015

Marathon Pharmaceuticals, a privately held US biopharmaceuticals company focused on drugs for people…

Marathon PharmaceuticalsMergers & AcquisitionsPharmaceuticalRare diseasesValeant Pharmaceuticals International

37 to 46 of 97856 results

COMPANY SPOTLIGHT

Menarini

Back to top